The Claim
In adults with type 2 diabetes, elevated levels of interleukin-6 and high-sensitivity C-reactive protein are independently associated with a 1.9- to 2.5-fold increased risk of major adverse cardiovascular events, including hospitalization for heart failure, ischemic heart disease, or stroke, over a median follow-up period of 11.4 years.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Adults with type 2 diabetes who have higher levels of interleukin-6 and high-sensitivity C-reactive protein have a 1.9- to 2.5-fold higher rate of serious heart events, such as heart failure, heart attacks, or strokes, over an average of 11.4 years of observation.
See the scientific wording
In adults with type 2 diabetes, elevated levels of IL-6 and hsCRP are independently associated with a 1.9- to 2.5-fold increased risk of major adverse cardiovascular events, including hospitalization for heart failure, ischemic heart disease, or stroke, over a median follow-up of 11.4 years.
Persistent high levels of inflammatory signals cause blood vessel lining to become damaged and sticky, leading to plaque buildup, blood clots, and blocked arteries that trigger heart attacks, strokes, or heart failure.
What the research says
1 studyIn people with type 2 diabetes, those with higher levels of two inflammation markers (IL-6 and hsCRP) were almost twice as likely to have a serious heart problem or stroke over the next 11 years, which is exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.